5 EASY FACTS ABOUT AGO TUMOR DESCRIBED

Molecular typing relies on molecular genetic tests and is not but routinely offered. Molecular subtypes and immunohistochemical surrogate markers with the tumors (HR, HER2, triple destructive) correlate in about 70%. The differentiation of luminal A and B subtypes by HR standing and proliferation markers like Ki-sixty seven could possibly be useful